3-9943989-T-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBS1_Supporting

The ENST00000326434.9(CRELD1):​c.1136T>G​(p.Met379Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000376 in 1,036,330 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M379T) has been classified as Benign.

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000019 ( 0 hom. )

Consequence

CRELD1
ENST00000326434.9 missense

Scores

2
14

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: -0.304

Publications

8 publications found
Variant links:
Genes affected
CRELD1 (HGNC:14630): (cysteine rich with EGF like domains 1) This gene encodes a member of a subfamily of epidermal growth factor-related proteins. The encoded protein is characterized by a cysteine-rich with epidermal growth factor-like domain. This protein may function as a cell adhesion molecule. Mutations in this gene are the cause of atrioventricular septal defect. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Apr 2010]
PRRT3 (HGNC:26591): (proline rich transmembrane protein 3) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.03431061).
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000145 (22/152034) while in subpopulation AMR AF = 0.00144 (22/15266). AF 95% confidence interval is 0.000976. There are 0 homozygotes in GnomAd4. There are 15 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CRELD1NM_001077415.3 linkc.1049-376T>G intron_variant Intron 10 of 10 ENST00000452070.6 NP_001070883.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CRELD1ENST00000452070.6 linkc.1049-376T>G intron_variant Intron 10 of 10 2 NM_001077415.3 ENSP00000393643.2
ENSG00000288550ENST00000683484.1 linkn.*697-376T>G intron_variant Intron 23 of 23 ENSP00000507040.1

Frequencies

GnomAD3 genomes
AF:
0.000145
AC:
22
AN:
152034
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00144
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000683
AC:
17
AN:
249054
AF XY:
0.0000742
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000492
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000192
AC:
17
AN:
884296
Hom.:
0
Cov.:
13
AF XY:
0.0000216
AC XY:
10
AN XY:
463536
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22698
American (AMR)
AF:
0.000386
AC:
17
AN:
44012
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
22544
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37038
South Asian (SAS)
AF:
0.00
AC:
0
AN:
74838
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53226
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4614
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
583780
Other (OTH)
AF:
0.00
AC:
0
AN:
41546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000145
AC:
22
AN:
152034
Hom.:
0
Cov.:
32
AF XY:
0.000202
AC XY:
15
AN XY:
74240
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41366
American (AMR)
AF:
0.00144
AC:
22
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10582
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68012
Other (OTH)
AF:
0.00
AC:
0
AN:
2088
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.459
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
637

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Atrioventricular septal defect, susceptibility to, 2 Uncertain:1
May 14, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is present in population databases (no rsID available, gnomAD 0.05%), and has an allele count higher than expected for a pathogenic variant. This sequence change replaces methionine, which is neutral and non-polar, with arginine, which is basic and polar, at codon 379 of the CRELD1 protein (p.Met379Arg). This variant has not been reported in the literature in individuals affected with CRELD1-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0"). ClinVar contains an entry for this variant (Variation ID: 627519).

Tetralogy of Fallot Uncertain:1
Apr 26, 2019
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
5.4
DANN
Benign
0.62
Eigen
Benign
-1.2
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.044
N
LIST_S2
Benign
0.24
T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.034
T
MetaSVM
Benign
-1.1
T
PhyloP100
-0.30
PrimateAI
Benign
0.29
T
PROVEAN
Benign
0.12
N
REVEL
Benign
0.049
Sift
Uncertain
0.0030
D
Sift4G
Uncertain
0.032
D
Vest4
0.21
ClinPred
0.045
T
GERP RS
1.7
gMVP
0.74
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73118372; hg19: chr3-9985673; API